NEW YORK, Sept 29 – Shares of chipmaker Ciphergen Biosystems (Nasdaq: CIPH) shot up more than 115 percent in their first day of trading on the Nasdaq on Friday.

The Fremont, Calif.-based company offered 5.5 million shares of its common stock for $16 per share. The offering, which was priced at the high-end of the $14-$16 range, raised $88 million.

In afternoon trading the shares were up 18 1/2, or 115.6 percent, at 34 1/2.

SG Cowen, was the lead managing underwriter and ING Barings and Warburg Dillon Read were co-managers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.